Cardiovascular — Lipid Particle
ApoB (Apolipoprotein B)
ApoB counts the number of atherogenic lipoprotein particles in circulation.
Reference range
Optimization target: ~<80 mg/dL (population-level). Functional optimization context only — not a diagnostic assertion. Range varies by lab, age, and sex.
Why it matters
ApoB is the single best blood marker for atherogenic lipoprotein burden — better than LDL-C in head-to-head studies, because every atherogenic particle (LDL, VLDL, IDL, Lp(a)) carries exactly one ApoB. A REVRCEL longevity panel reads ApoB as the primary cardiovascular risk lever rather than relying on the standard lipid panel alone. Modifiable through diet, exercise, GLP-1 therapy, and — when warranted — lipid-lowering medication.
How REVRCEL clinicians read it
ApoB is interpreted against age, family history, and Lp(a). Lifestyle is the first lever; pharmacotherapy is layered when indicated.
Included in
- Core Bloodwork
Common questions
Why is ApoB better than LDL?
ApoB counts particles; LDL-C measures cholesterol content per particle. Particle count is the better predictor of cardiovascular events.
What ApoB level is optimal?
Lower is generally better in the longevity literature. Targets are individualized.
Related biomarkers
Statements have not been evaluated by the FDA. This page is educational and is not medical advice.